Acute SARS-CoV-2 infection

Posted by Michael Jannicelli | Oct 24, 2025 | Uncategorized | 0 |

Nature Reviews Disease Primers, Published online: 24 October 2025; doi:10.1038/s41572-025-00665-8

This PrimeView highlights the pathophysiology of acute SARS-CoV-2 infection and summarises its epidemiology, diagnosis, management and areas for future research. It accompanies the Primer on this topic by Sherman and colleagues.

About The Author

Michael Jannicelli

Michael Jannicelli - "A PROVEN BUSINESS FIRESTARTER & BRANDING GENIUS" a true natural born Trendsetter. • Created over 100 products under 3 brands, sold in 30+ countries worldwide and influencing youth across the globe. • Featured in Forbes magazine +over 100 print publications, television talk shows, major motion pictures and national radio stations. • Co-founder and VP of Bliss beverage USA and President/co-founder of Socko International - fastest growing privately held beverage company in US (Forbes) with Hogan Energy & Raw Energy WWE. • Co-founder of Throwdown Industries (2003) - leading brand in multibillion dollar Impact/Action Sports Market (products designed for superior MN • Diagnosed with auto-immune diseases aged 13; using his experience to help others and promote a positive message while developing edgy products to benefit people with chronic illness.